Sharps Compliance (NASDAQ:SMED) Upgraded by ValuEngine to Hold

ValuEngine upgraded shares of Sharps Compliance (NASDAQ:SMED) from a sell rating to a hold rating in a report published on Thursday, ValuEngine reports.

Other equities analysts have also issued reports about the company. Robert W. Baird began coverage on Sharps Compliance in a research note on Wednesday, July 24th. They issued a buy rating and a $4.50 price objective on the stock. Zacks Investment Research raised Sharps Compliance from a hold rating to a buy rating and set a $4.50 price objective on the stock in a research note on Wednesday, September 18th. Roth Capital began coverage on Sharps Compliance in a research note on Wednesday, July 24th. They issued a buy rating and a $4.50 price objective on the stock. Barrington Research reaffirmed an outperform rating and issued a $6.00 price objective (up from $5.00) on shares of Sharps Compliance in a research note on Tuesday, October 29th. Finally, TheStreet raised Sharps Compliance from a d+ rating to a c- rating in a research note on Wednesday, August 21st. One investment analyst has rated the stock with a hold rating and four have issued a buy rating to the company’s stock. The company currently has a consensus rating of Buy and an average price target of $4.88.

NASDAQ:SMED traded down $0.01 during mid-day trading on Thursday, reaching $3.86. The company’s stock had a trading volume of 56,100 shares, compared to its average volume of 22,447. The company’s fifty day simple moving average is $4.40 and its two-hundred day simple moving average is $3.82. The company has a debt-to-equity ratio of 0.30, a current ratio of 1.99 and a quick ratio of 1.66. Sharps Compliance has a twelve month low of $2.97 and a twelve month high of $5.25. The stock has a market cap of $65.39 million, a P/E ratio of 386.00, a P/E/G ratio of 3.00 and a beta of 0.28.

Sharps Compliance (NASDAQ:SMED) last issued its quarterly earnings results on Wednesday, October 23rd. The industrial products company reported $0.04 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.01 by $0.03. The firm had revenue of $13.60 million for the quarter, compared to analyst estimates of $11.30 million. Sharps Compliance had a return on equity of 3.16% and a net margin of 1.74%. Sell-side analysts expect that Sharps Compliance will post 0.06 EPS for the current fiscal year.

Hedge funds and other institutional investors have recently added to or reduced their stakes in the company. BlackRock Inc. lifted its stake in shares of Sharps Compliance by 3.8% in the 2nd quarter. BlackRock Inc. now owns 108,739 shares of the industrial products company’s stock valued at $387,000 after purchasing an additional 4,013 shares in the last quarter. Lapides Asset Management LLC lifted its stake in shares of Sharps Compliance by 13.3% in the 2nd quarter. Lapides Asset Management LLC now owns 164,700 shares of the industrial products company’s stock valued at $586,000 after purchasing an additional 19,300 shares in the last quarter. Morgan Stanley lifted its stake in shares of Sharps Compliance by 34.3% in the 2nd quarter. Morgan Stanley now owns 188,699 shares of the industrial products company’s stock valued at $672,000 after purchasing an additional 48,199 shares in the last quarter. North Star Investment Management Corp. lifted its position in Sharps Compliance by 9.8% during the 3rd quarter. North Star Investment Management Corp. now owns 271,575 shares of the industrial products company’s stock worth $1,127,000 after acquiring an additional 24,150 shares in the last quarter. Finally, Wells Fargo & Company MN lifted its position in Sharps Compliance by 8.3% during the 2nd quarter. Wells Fargo & Company MN now owns 424,814 shares of the industrial products company’s stock worth $1,512,000 after acquiring an additional 32,600 shares in the last quarter. 16.92% of the stock is currently owned by institutional investors and hedge funds.

About Sharps Compliance

Sharps Compliance Corp. provides medical, pharmaceutical, and hazardous waste management services in the United States. It offers Sharps Recovery System for the containment, transportation, treatment, and tracking of medical waste and used healthcare materials generated outside the hospital and health care facility settings; TakeAway Medication Recovery System, a solution that facilitates the proper disposal of unused medications; MedSafe, a solution for the safe collection, transportation, and proper disposal of unwanted and expired prescription medications; and ComplianceTRAC, a Web-based compliance and training program.

See Also: How to Invest in Growth Stocks

To view ValuEngine’s full report, visit ValuEngine’s official website.

Receive News & Ratings for Sharps Compliance Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sharps Compliance and related companies with MarketBeat.com's FREE daily email newsletter.